Hidden danger: why some patients can't shake COVID-19
NCT ID NCT06576102
First seen Jun 01, 2026 · Last updated Jun 12, 2026 · Updated 4 times
Summary
This study tracked 204 patients with blood cancers or those on certain immune-suppressing treatments to see how often COVID-19 infection persists for 21 days or more. Researchers also looked for factors that make a long infection more likely. The goal was to better understand who is at risk, not to test a new treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PERSISTENT COVID-19 are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
AOUI Verona
Verona, Verona, 37126, Italy
-
Hospital Virgen Macarena
Seville, Seville, 41009, Spain
-
IRCCS Humanitas
Milan, Milan, 20089, Italy
-
IRCCS INMI L. Spallanzani
Roma, Roma, 00149, Italy
-
Irccs Aoubo
Bologna, Bologna, 40138, Italy
Conditions
Explore the condition pages connected to this study.